← Back to patent-cliff list
比索洛尔贴剂（Toa Eiyo）
Tier C — Watch / tradeBisoprolol Patches(Toa Eiyo)
Toa Eiyo Ltd
Originator
2013
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ADRB1
Brand：Bisono、宾索诺
Indications (approved)：心动过速、心房颤动、原发性高血压
Regional status
US
-
EU
-
China
申请上市
2026-06-18
Japan
批准上市
2013-06-28
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Bisoprolol Patches(Toa Eiyo)?
Approved indications include: 心动过速, 心房颤动, 原发性高血压.
When does the Bisoprolol Patches(Toa Eiyo) patent expire?
No public expiry year is available for Bisoprolol Patches(Toa Eiyo) yet; this page updates once verified.
How do I get a quote for Bisoprolol Patches(Toa Eiyo) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24